Literature DB >> 9990182

Pharmacy access to sterile syringes for injection drug users: attitudes of participants in a syringe exchange program.

B Junge1, D Vlahov, E Riley, S Huettner, M Brown, P Beilenson.   

Abstract

OBJECTIVE: To examine attitudes of participants of a van-based syringe exchange program (SEP) toward the hypothetical prospect of pharmacy-based syringe access.
DESIGN: One-time, cross-sectional survey.
SETTING: Baltimore, Maryland. PARTICIPANTS: 206 injection drug users who participate in the Baltimore SEP.
INTERVENTIONS: Face-to-face interviews. MAIN OUTCOME MEASURES: Location preferred for obtaining syringes, drug and syringe use, past experience with pharmacies, and willingness to pay.
RESULTS: The sample was 67% men, 95% African American, and 95% unemployed; mean age was 39.8 years. A total of 19% of respondents had bought syringes at a pharmacy during the prior six months. Some 37% reported having been turned down when asking for syringes at a pharmacy, most commonly due to lack of identification to prove diabetic status (50%). If legal restrictions were lifted, 92% of respondents would obtain syringes from pharmacies, and would be willing to pay a mean price of $0.80 (median = $1.00) per syringe. Women were more likely than men to report the intention to switch from van-based SEP to pharmacy (57% versus 38%, p = .045).
CONCLUSION: If current legal restrictions were lifted, pharmacies would be a viable syringe source appealing particularly to women, suggesting gender-specific access issues that should be addressed. The per-syringe price that study participants would be willing to pay exceeds typical retail prices, suggesting that pharmacists could charge enough per syringe to recoup operational costs.

Entities:  

Mesh:

Year:  1999        PMID: 9990182     DOI: 10.1016/s1086-5802(16)30410-7

Source DB:  PubMed          Journal:  J Am Pharm Assoc (Wash)        ISSN: 1086-5802


  7 in total

1.  Characteristics and utilization patterns of needle-exchange attendees in Chicago: 1994-1998.

Authors:  H Brahmbhatt; D Bigg; S A Strathdee
Journal:  J Urban Health       Date:  2000-09       Impact factor: 3.671

2.  Demographic, risk, and spatial factors associated with over-the-counter syringe purchase among injection drug users.

Authors:  Thomas J Stopka; Alexandra Lutnick; Lynn D Wenger; Kathryn Deriemer; Estella M Geraghty; Alex H Kral
Journal:  Am J Epidemiol       Date:  2012-05-04       Impact factor: 4.897

3.  Nonprescription naloxone and syringe sales in the midst of opioid overdose and hepatitis C virus epidemics: Massachusetts, 2015.

Authors:  Thomas J Stopka; Ashley Donahue; Marguerite Hutcheson; Traci C Green
Journal:  J Am Pharm Assoc (2003)       Date:  2017-02-08

4.  Factors associated with presence of pharmacies and pharmacies that sell syringes over-the-counter in Los Angeles County.

Authors:  Thomas J Stopka; Estella M Geraghty; Rahman Azari; Ellen B Gold; Kathryn Deriemer
Journal:  J Urban Health       Date:  2013-12       Impact factor: 3.671

Review 5.  Syringe availability as HIV prevention: a review of modalities.

Authors:  P Coffin
Journal:  J Urban Health       Date:  2000-09       Impact factor: 3.671

6.  Increasing syringe access and HIV prevention in California: findings from a survey of local health jurisdiction key personnel.

Authors:  Thomas J Stopka; Richard S Garfein; Alessandra Ross; Steven R Truax
Journal:  J Urban Health       Date:  2007-01       Impact factor: 3.671

7.  Willingness to pay for health care services in common cold, retinal detachment, and myocardiac infarction: an internet survey in Japan.

Authors:  Hideo Yasunaga; Hiroo Ide; Tomoaki Imamura; Kazuhiko Ohe
Journal:  BMC Health Serv Res       Date:  2006-02-20       Impact factor: 2.655

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.